(Q40365247)

English

Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer

scientific article published on March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer (English)

1 reference

Europe PubMed Central

19 September 2017

0 references

author name string

Yoshihisa Namiki

1

1 reference

Europe PubMed Central

19 September 2017

Tamami Namiki

2

1 reference

Europe PubMed Central

19 September 2017

Hiroshi Yoshida

3

1 reference

Europe PubMed Central

19 September 2017

Masataka Date

4

1 reference

Europe PubMed Central

19 September 2017

Masakazu Yashiro

5

1 reference

Europe PubMed Central

19 September 2017

Kunio Matsumoto

6

1 reference

Europe PubMed Central

19 September 2017

Toshikazu Nakamura

7

1 reference

Europe PubMed Central

19 September 2017

Kazuyoshi Yanagihara

8

1 reference

Europe PubMed Central

19 September 2017

Norio Tada

9

1 reference

Europe PubMed Central

19 September 2017

Jujin Satoi

10

1 reference

Europe PubMed Central

19 September 2017

Kiyotaka Fujise

11

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

1 March 2006

1 reference

Europe PubMed Central

19 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

19 September 2017

118

1 reference

Europe PubMed Central

19 September 2017

6

1 reference

Europe PubMed Central

19 September 2017

1545-1555

1 reference

Europe PubMed Central

19 September 2017

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin/5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: cationic liposomal gene therapy of carcinomatosa

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Stimulation of transcription accompanying relaxation of chromatin structure in cells overexpressing high mobility group 1 protein.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Improved green fluorescent protein by molecular evolution using DNA shuffling.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Enzyme-linked immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

A new method for preparation of phospholipid vesicles (liposomes) - french press

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.21531

21 January 2018

Identifiers

10.1002/IJC.21531

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40365247&oldid=1896226338"